Flavonoids as multi-target protective agents against aflatoxin B1 toxicity: mechanistic convergence and translational challenges Authors: Huanhuan Shi, Jie Mu, Rong Li, Kesong Zhu, Yiming Long, Yalin Lin, Danchen Zhao, Mengnan Qu Published: 2026 ABSTRACT AbstractAflatoxin B1 (AFB1) is the most widespread and toxic mycotoxin found in food and feed. It is both chemically and physically stable and shows resistance to degradation during processing. AFB1 can cause damage to multiple organs, including the liver, immune system, nervous system, kidneys, reproductive system, intestines, and genetic material. Therefore, the development of a safe and effective antidote is urgently needed. Flavonoids are a class of natural polyphenols widely found in fruits, vegetables, and herbs, which can mitigate AFB1-induced organ toxicity through various mechanisms. However, the precise molecular mechanisms responsible for their detoxifying actions have yet to be systematically characterized and fully elucidated. Therefore, this review systematically summarizes the protective effects of flavonoids (including flavones, flavonols, dihydroflavones, dihydroflavonols, isoflavones, flavanols, chalcones, and anthocyanins, among others) against AFB1-induced multi-organ toxicity. These flavonoids primarily exert their protective effects by targeting multiple key pathways, including activation of the Nrf2/ARE antioxidant system, inhibition of the NF-κB/NLRP3 inflammatory axis, regulation of the Bax/Bcl-2/Caspase-3 apoptotic cascade, suppression of ferroptosis via the GPX4/xCT/ACSL4 pathway, and modulation of the gut-liver/spleen axis. This review provides a mechanistic basis for the development of flavonoid-based AFB1 detoxification strategies.Keywords: Aflatoxin B1, Flavonoids, Oxidative stress, Ferroptosis, Gut microbiota Introduction AFB1 is considered one of the most toxic and widespread mycotoxins worldwide and is primarily produced by Aspergillus flavus and Aspergillus parasiticus (Zhang et al., 2022b; Che et al., 2023). AFB1 is widely found in improperly stored crops and feed, and its contamination has resulted in an increasing incidence and severity of poisoning in both humans and poultry, thereby posing significant food safety risks (Cheng et al., 2023). Exposure to AFB1 can induce hepatotoxicity (Gramantieri et al., 2022), neurotoxicity (Alsayyah et al., 2019), immunotoxicity (Najafi et al., 2020), reproductive toxicity (Zhang et al., 2022b), gastrointestinal toxicity (Huang et al., 2024), and damage to other organs. The sources, metabolic activation, and toxic effects of AFB1 are summarized in Fig. 1. Among these toxic effects, hepatotoxicity is the most common, and chronic exposure may contribute to the development of hepatocellular carcinoma (HCC) (Rojanapo et al., 1993; Ge et al., 2024). Consumption of AFB1-contaminated feed can induce liver injury and immunosuppression in poultry, leading to reduced production performance, increased disease susceptibility, higher treatment costs, and elevated mortality rates (Liu et al., 2023a; Qiu et al., 2024). Furthermore, AFB1 and its metabolites can accumulate in edible tissues and poultry-derived products. Consequently, consumption of contaminated poultry products and eggs may expose humans to AFB1, thereby increasing the risks of carcinogenesis, teratogenesis, and immune dysfunction, which poses a substantial threat to public health (Muharremi et al., 2021; Awuor et al., 2025; Aydemir Atasever et al., 2025). Therefore, elucidating the toxicological mechanisms of AFB1 and developing effective intervention strategies are of considerable importance for safeguarding public health. The schematic illustrates the sources, metabolic activation, and toxic effects of AFB1. AFB1 primarily contaminates crops, fruits, and common food items. Upon entering the body, AFB1 is metabolized by CYP450 (a cytochrome P450 enzyme) into the reactive intermediate aflatoxin B1-exo-8,9-epoxide (AFBO). This epoxide exhibits potent toxicity, leading to multiple organ toxicities, including hepatotoxicity, nephrotoxicity, neurotoxicity, immunotoxicity, and reproductive toxicity. In recent years, increasing attention has been devoted to the use of natural products for mitigating AFB1-induced toxicity. Among these natural compounds, flavonoids have attracted considerable interest because of their diverse biological activities, including antioxidant, anti-inflammatory, antibacterial, antiviral, and antitumor effects. Flavonoids are a class of natural polyphenolic compounds widely distributed throughout the plant kingdom and are particularly abundant in fruits, vegetables, herbs, and flowers (Fehily et al., 2026). Flavonoids share a common C6–C3–C6 carbon skeleton (2-phenylchromone). Structurally, they are mainly divided into oxidized and reduced forms. Based on the oxidation state of the C-ring and different substitution patterns, they can be further categorized into several subclasses (flavones, flavonols, isoflavones, chalcones, flavan-3-ols, anthocyanidins, aurones, flavanones, dihydroflavonols, isoflavanones, dihydrochalcones, flavonolignans, flavan-3,4-diols, xanthones, homoisoflavonoids, and lignoflavonoids) (Adedara et al., 2021; Lin et al., 2025a). The structures of representative flavonoid compounds are shown in Figure S1 of the supporting information. Flavonoids exert therapeutic and preventive effects on a variety of AFB1-induced pathological conditions, including metabolic disorders, cancer, inflammatory diseases, and immune dysfunction (Wang et al., 2023a; Lin et al., 2025b; Naeini et al., 2025). To date, several reviews related to AFB1 toxicity or mitigation measures have been published. Khan et al. provided a broad survey of mycotoxin toxicology and mitigation approaches, with flavonoids listed as one category among many phytochemicals (Khan et al., 2024). Huang et al. and Sharifi et al. covered nutritional interventions and feed safety strategies within broad frameworks where flavonoids were mentioned but not systematically examined (Huang et al., 2026; Sharifi et al., 2026). Therefore, by summarizing the studies on the detoxification of AFB1 by flavonoids, we systematically sorted out the categories, effects, and mechanisms of flavonoids, with particular emphasis on the protective roles of flavonoids against AFB1-induced toxicity. In addition, we also summarized the physicochemical characteristics, toxicological effects, and molecular mechanisms of AFB1, This review aims to provide a theoretical basis for the development of safe and effective flavonoid-based interventions and to offer future research directions for mitigating AFB1-associated health risks. The toxic effects of AFB1 Accumulating evidence indicates that AFB1 exerts multi-organ toxicity, specifically affecting the nervous, immune, renal, hepatic, and reproductive systems, as outlined in Table 1. Table 1Toxicity of AFB1 in different tissues and organs.ModelsOrgan / TissueDose and timeEffectsMechanismsRef.RatsCerebrum; Cerebellum.75 µg/kg b.w. for 28 d.Anxiety-like behavior and motor dysfunction.Oxidative stress, inflammation, andApoptosis.(Adedara et al., 2021)RatsHippocampus; Cortex.0.75 and 1.5 mg/kg b.w. for 30 d.Cognitive decline anddepressive-like behavior.Oxidative stress, inflammation, and neurotransmitter dysregulation.(Okoro et al., 2024)Mice;HT22.HippocampusMice: 1.5 mg/L (in drinking water) for 8 weeks. Cells: 30 µmol/L for 24 and 48 h.Cognitive decline and AD.Cognitive decline and AD.Oxidative stress; Ferroptosis.(Lin et al., 2025a)MiceHippocampus0.1 mg/kg b.w. for 12 weeks.Dyslipidemia; Inflammation.(Lin et al., 2025b)Mice; IMR-32 .Brain; Neurons.Mice: 300 µg/kg b.w. for 30 d; Cells: 6 µg/mL for 12–48 h.NeurotoxicityROS↑; DNA damage↑; apoptosis.(Huang et al., 2020)MicrogliaNeurons0.5–2 µmol/L,incubation for 24–48 hNeuronal damage.Inflammation; Pyroptosis.(Zhang et al., 2022a)ZebrafishBrain5. 20 µg/L for 7 d.Neurobehavioral abnormalities.Dyslipidemia; Oxidative stress; Inflammation and apoptosis.(Wang et al., 2023d)MiceIntestines0.5, 1.5, and 5 mg/L in drinking water for 21 d.Reduced immune cellsPopulations.Increased sEH expression;Lipid metabolism disorders.(Wang et al., 2023b)MiceIntestines0.75 mg/kg b.w. for 4 weeks.Villus shortening and crypt.hyperplasiaOxidative stress; Inflammation; Immunotoxicity.(Li et al., 2024)MiceSpleen; Intestines.0.3 µg, 7.5 µg, 100 µg/kg b.w, long-term exposure.Enhanced immune response.IL-4, IL-5, and IL-13 secretion ↑;IFN-γ production↓.(Deng et al., 2023)MiceLiver–Gut Axis25 µg/kg b.w./d for 28 d.Gut microbiota dysbiosis and impaired colonic barrier functionHepatic pyroptosis and inflammation via the gut–liver axis.(Ye et al., 2023)ChickensLiver1 mg/kg b.w./d for 28 d.Liver injury.Activates the TLR4/RIPK pathway, inducing necrotic apoptosis and inflammation.(Li et al., 2022d)Broiler chickens.Thymus; Spleen; Bursa of Fabricius.5 mg/kg b.w./d for 28 d.Atrophy of the immune organs.Oxidative stress; Immunosuppression.(Li et al., 2022c)Broiler chick; RAW 264.7.Thymus, spleen, liver, muscles, bursaBroiler chick: 2 mg/kg b.w./d for 28 d.Cells: 15 mmol/L for 48 hWeakenedimmune response.Oxidative stress; Ferroptosis; LipidPeroxidation.(Xia et al., 2024)Laying hensLiver.0.6 mg/kg b.w./d for 35 d.Hepatic lipidaccumulation and hepatocyte apoptosis.PPARγ signaling pathway dysregulation.(Liu et al., 2020)RatsLiver, kidneys.250 µg/kg b.w./d for 14 d.Liver and kidney damage.GST and CAT ↑.(Deng et al., 2023)RatsLiver250 µg/kg b.w./d for 14 d.DNA damageand HCC.Genotoxicity and DNA damage.(Gramantieri et al., 2022)RAW264.7/5, 50, 100 µmol/L for 24 and 48 h.Impaired immune function.Activate the NF-κB/PI3K-Akt/mTOR pathways(Ma et al., 2021)LeghornsLiver, kidneys.5 mg/kg b.w. for 24 h.Elevated levels of ALT, AST, CRE, and BUN.Induce the release of HETs and regulate the immune response;(Gao et al., 2022)Channa argusLiver.50, 100, 200, 400 ppb for 8 weeks.Growth inhibition, immunosuppression, liver damage.Oxidative stress; Endoplasmic reticulum stress; Inflammation andApoptosis.(Li et al., 2022a)RatsLiver, kidneys, spleen, testicles, blood.0.5 mg/kg b.w., 21 d.Multi-organ toxicity.Oxidative stress; Inflammation; Immunosuppression and apoptosis.(Subramaniam et al., 2022)MiceKidneys.0,0.5,0.75,1mg/kg b.w./d for 28 d.Mitochondrial damage.Oxidative stress; Apoptosis.(Wang et al., 2022a)Hek293/32.6 µmol/L,exposed for 24 h.Cells death.Oxidative stress; Apoptosis.(Dlamini et al., 2021)Yak oocytes/1 nmol/l; ensure that at least 50% of oocytes develop to the MII stage.Decline inoocyte fertilization capacity andparthenogenetic ability.Oxidative stress; Apoptosis.(Li et al., 2022b)Mice;Porcine Sertoli cells.Testicles, intestines, blood.Mice: 200 µg/kg.b.w. for 28 d;Cells: 2.5 µg/mL, incubation for 24 h.Sperm concentration ↓;Rate of sperm abnormalities↑.Inhibits the PI3K-AKT signaling pathway and activates the intestinalNLRP3 signaling pathway.(Zhang et al., 2024)HT22: Mouse hippocampal neuron cells, IMR-32: Institute for Medical Research-32 cells, RAW264.7: Mouse macrophage cells, Hek293, Human Embryonic Kidney 293 cells; AD: Alzheimer's disease; GSDMD: gasdermin D, sEH: Soluble epoxide hydrolase, IFN-γ: Interferon-gamma, IL-4: Interleukin-4, IL-5: Interleukin-5, IL-13: Interleukin-13, ALT: Alanine Aminotransferase, AST: Aspartate Aminotransferase, CRE: Creatinine, BUN: Blood Urea Nitrogen, GST: Glutathione S-transferase. Toxicity of AFB1 in different tissues and organs. HT22: Mouse hippocampal neuron cells, IMR-32: Institute for Medical Research-32 cells, RAW264.7: Mouse macrophage cells, Hek293, Human Embryonic Kidney 293 cells; AD: Alzheimer's disease; GSDMD: gasdermin D, sEH: Soluble epoxide hydrolase, IFN-γ: Interferon-gamma, IL-4: Interleukin-4, IL-5: Interleukin-5, IL-13: Interleukin-13, ALT: Alanine Aminotransferase, AST: Aspartate Aminotransferase, CRE: Creatinine, BUN: Blood Urea Nitrogen, GST: Glutathione S-transferase. Neurotoxicity The neurotoxicity of AFB1 is primarily manifested as the induction of neurobehavioral abnormalities, with the severity of toxicity being dose- and time-dependent. Long-term exposure to AFB1 leads to a significant reduction in the activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) in the brain tissue of rats and mice (Alsayyah et al., 2019). AFB1 can also activate the necrotic apoptosis pathway, upregulating the expression of cysteine-aspartic acid protease 3 (caspase-3), leading to neuronal apoptosis (Adedara et al., 2021; Naeini et al., 2025) and activating the LRR and PYD domains-containing protein 3 (NLRP3) inflammasome, making neurons more susceptible to oxidative damage and neuroinflammation, which in turn leads to neuropathy and induces related diseases (Zhang et al., 2022a; Wang et al., 2023a; Lin et al., 2025b). In addition, AFB1 can disrupt the normal functioning of various neurotransmitter systems, with the cholinergic, dopaminergic, and indolaminergic pathways being particularly affected (Adedara et al., 2021; Okoro et al., 2024; Owumi et al., 2025a, 2025b). Immunotoxicity AFB1 interference with the immune system may lead to immunosuppression, increase the risk of infection, and promote the onset and progression of cancer. Previous study has shown that AFB1 poisoning directly damages the structure and function of central immune organs. AFB1 induces lymphocytopenia in the white pulp, focal hemorrhage, and hemosiderin deposition (Ashi et al., 2023), as well as organ atrophy, thymocyte apoptosis, and disruption of T-cell subsets (Li et al., 2022c). It also causes atrophic lesions and disrupts the microenvironment for B-lymphocyte development in the bursa of Fabricius (Li et al., 2022c; Xia et al., 2024). Beyond its effects on lymphoid organs, the toxicity of AFB1 directly affects various immune cells. For example, it promotes apoptosis and upregulates the expression of interleukin-1 beta (IL-1β) (Ma et al., 2021; Mo et al., 2023; Wang et al., 2023b). Moreover, AFB1 triggers excessive release of extracellular traps, leading to their overproduction and subsequent tissue damage (Gao et al., 2022). As a common foodborne toxin, AFB1 significantly disrupts the intestinal immune barrier by reducing the expression of tight junction proteins (Mo et al., 2023; Li et al., 2024). Hepatotoxicity The liver is the primary target organ for AFB1, and exposure to AFB1 can induce a range of liver injuries. Studies have shown that AFB1 significantly increases levels of reactive oxygen species (ROS) and malondialdehyde (MDA), while simultaneously reducing the activity of SOD, CAT, and glutathione (GSH), thereby disrupting redox homeostasis (Li et al., 2022a, 2022d). Furthermore, AFB1 can disrupt the balance of the gut microbiota, thereby exacerbating liver inflammation via the gut-liver axis (Liu et al., 2022; Ye et al., 2023), Other study has shown that AFB1 exposure can suppress the expression of the intestinal Farnesoid X receptor (FXR), affecting bile acid metabolism, leading to changes in the composition of intestinal bile acids and increasing the burden on the liver (Liu et al., 2023b). High doses of AFB1 can trigger the onset and progression of HCC, while chronic or intermittent low-dose AFB1 intake may also lead to its accumulation in the liver and potentially result in the development of liver cancer (Gramantieri et al., 2022). AFB1 also influences hepatic lipid accumulation and apoptosis by affecting the expression levels of protein-coding genes and microRNAs (miRNAs) (Liu et al., 2020). Nephrotoxicity The nephrotoxic effects of AFB1 have been confirmed in multiple animal models and human studies, with exposure causing varying degrees of kidney injury. AFB1 exposure disrupts redox homeostasis in renal cells, leading to excessive generation of ROS and reactive nitrogen species (RNS), which subsequently damage renal tubular cells (Wang et al., 2022a). Multiple studies have demonstrated that AFB1 can activate the intrinsic apoptotic pathway, upregulating tumor protein p53 (p53), Bcl-2-associated X protein (Bax), cysteine-aspartic protease 3 (Caspase-3), and cysteine-aspartic protease 3 (Caspase-9), while downregulating key anti-apoptotic proteins such as B-cell lymphoma-2 (Bcl-2) (Dlamini et al., 2021; Owumi et al., 2023b; Ma et al., 2025). AFB1-induced release of heterophil extracellular traps (HETs) significantly increases serum levels of creatinine (CRE), blood urea nitrogen (BUN), and cystatin C (Cys-C), accompanied by renal histopathological alterations and elevated blood uric acid (UA) levels (Ismail et al., 2020; Li et al., 2022e; Owumi et al., 2023c; Albadrani et al., 2024). Furthermore, AFB1 exposure induces histopathological alterations and apoptosis in renal tissues (Qing et al., 2022). Reproductive toxicity AFB1 exhibits significant toxicity in both the male and female reproductive systems, as demonstrated in multiple animal models, and also exerts clear toxicity on mammalian oocyte development. Reducing GSH levels and increasing ROS levels while upregulating Bax (Wu et al., 2022) and downregulating Bcl-2 and DNA methyltransferase 3 beta (DNMT3b), AFB1 may impair developmental potential via induction of apoptosis and epigenetic alterations (Hajarizadeh et al., 2022). Similarly, AFB1 and its metabolite aflatoxin M1 (AFM1) delay cleavage progression, alter mitochondrial function and associated gene expression, and impair embryonic development (Yaacobi-Artzi et al., 2023). Reproductive toxicity induced by AFB1 primarily manifests as testicular tissue damage and germ cell dysfunction. Exposure to AFB1 reduces sperm quality and induces testicular inflammation, a process associated with abnormal activation of the tumor necrosis factor (TNF) and the PI3K-AKT signaling pathway (Zhang et al., 2024; Dong et al., 2025). Furthermore, AFB1 inhibits lactate secretion by Sertoli cells, thereby disrupting metabolic support for germ cells (Han et al., 2023). The antitoxic effects of flavonoids against AFB1-induced toxicity Flavonoids can antagonize AFB1 toxicity through multiple mechanisms. Representative flavonoid compounds that have been shown to provide protection against AFB1-induced toxicity in vitro and in vivo studies are listed in Table 2. These include flavonoids (luteolin (LUT), apigenin (API), genkwanin (GNK), dihydroflavone (Diosmetin (DIOS), baicalin (BAL)), and flavanols (quercetin (QUE), rutin (RUT), fisetin (FIS)); dihydroflavonoids (hesperidin (HES), naringin, naringenin); dihydroflavonols (silybin (SIL)), isoflavones (isoflavone (IXN)), Tectorigenin (TEC)); chalcones (Phloretin (PHL)), licochalcone A (Lico A)); flavan-3-ols (catechins, epigallocatechin gallate (EGCG)), proanthocyanidins (PACs)) and anthocyanins (cyanidin-3-O-glucoside (C3G)); flavonolignan (Dihydromyricetin, DHM)). Table 2Antagonistic effects of flavonoids on AFB1.Compound NameModelsDosage and TimeEffectsMechanismsRef.LUTRatsLUT (0.75 mg/kg b.w./d) for 14 d.Reversing liver damage.MDA and ROS↓;CAT and SOD↑.(Zaki et al., 2023)APIRatsSBE-HP (5, 10 mg/kg b.w./d) for 28 d.Restoration of liver and kidney function.Antioxidant; Anti-inflammatory and anti-apoptotic effects.(Owumi et al., 2023a)GNKRatsGNK (5, 10, 20 mg/kg b.w./d) for 56 d.Amelioration of multi-organ damage.Antioxidant and anti-inflammatory effects.(Ijaz et al., 2022)DIOSMiceDIOS (20 mg/kg.b.w/d) for 28 d.Reversing liver damage.Inhibits the NF-κB pathway and activates the PI3K/AKT pathway.(Li et al., 2025b)BALDucklingsBAL (25–100 mg/kg.b.w/d) for 7 d.Alleviates liver injury and improves growth performance.Increases albumin levels and decreases serum transaminase levels.(Lu et al., 2025)QUEMice and BFH12Mouse: Que (30 mg/kg b.w./3 d) for 45 d; Cells: QUE (10–30 μM) for 48 h.Protection of liver cells.Regulates metabolic enzymes; antioxidant, anti-inflammatory, and anti-apoptotic.(Gugliandolo et al., 2020; Pauletto et al., 2023; Li et al., 2025a)RUTRatsRUT (1 and 10 mg/100 g in the diet), followed by an AFB1 injection after 2 weeks.Reduces single-strand DNA breaks in the liver and suppresses the increased activity of repair enzymes.Inhibits the activation of carcinogens and scavenges free radicals.(Rose et al., 1996)RatsRUT (50 mg/kg.b.w/d) for 30 d.Alleviates depression-like behaviors and cognitive impairments.AChE, IL-6, NO, and MPO↓.(Okoro et al., 2024)FISRatsFIS (20 mg/kg.b.w/d), starting 6 weeks after AFB1 injection for 4 weeks.Inhibiting the progression of HCC.Decreasing PDK1/Akt phosphorylation.(Brajesh Kumar and Surendra Kumar, 2018)RatsFis (20mg/kg.b.w/d) for 10 weeks.Inhibiting the progression of HCC.Antioxidant; Anti-inflammatory.(Maurya and Trigun, 2016)HESMice; HT22Mice: HES (20, 40mg/kg.b.w/d) for 21 d.Cells: HES (50 µmol/L) for 36 h.Improve structural damage to the hippocampus, synaptic dysfunction, learning difficulties, and spatial memory.Alleviates endoplasmic reticulum (ER) stress-induced apoptosis..(Song et al., 2023)Mice, HepG2Mice: HES (20, 40 mg/kg b.w.) for 21 d; Cells: HES (150 µmol/L).Improves structural damage to the liver and liver fibrosis.Inhibits ferroptosis and reduces lipid peroxidation by regulating the PI3K/AKT/mTOR/ULK1 pathway(Song et al., 2024)NaringinRatsNaringin (5 mg/kg.b.w/d), 3 days after discontinuing AFB1 for 4 weeks.Improving the effectiveness of liver cancer treatment.TNF-α, IL-6, and IL-8↓.(Wang et al., 2021)NaringeninMiceMoringa leaf extract (400 mg/kg b.w./d) for 5 d, then combined with AFB1 for 30 d.Reversing liver damage.Activates the PPARγ/Nrf 2 signaling pathway .(Chen et al., 2026)DHMMiceDHM (200 mg/kg.b.w/d) for 37 d.Reversing liver damage.GST, GPX, CAT, and SOD↑;MDA levels↓.(Zhu et al., 2023)IXNTumor/Functional CellsIXN 0.1–200 μM (Tumor cells) and 10–100 μM (Functional Cells) for 2–48 h.Inhibits the activation of carcinogens.Inhibits CYP450 and regulates JAK/STAT and TGF-β.(Anna et al., 2015)TECRats; Rats Salmonella Typhi TA100Rats: TEC (10 mg/kg.b.w/d) for 7 d; TA100: Tec (0.25–1.0 mg/dish) for 48 h.Anti-mutagenic, anti-lipid peroxidation.Inhibits AFB1 activation and scavenges ROS.(Park et al., 2002)PHLHLMs (Pool1008); AML12microsomes: PHL (5–50 μM), pre-incubate for 10 minutes, then co-incubate with AFB1 for 90 minutes; AML12 cells: Phl 20 μM for 18 h.Inhibits AFB₁ activation and induces GST detoxification.Reduces AFBO production and activates Nrf2/ARE.(Gao et al., 2012)Lico ABroiler chickensLico A (50 mg/kg of diet) for 28 d.Reduces immunotoxicity.Inhibits ferroptosis, apoptosis, and mitochondrial damage.(Xia et al., 2024)catechinsCaco-2; HepG2This is sufficient to mitigate the toxicity of AFB1.Protects cell viability and inhibits toxic activation.Competitively blocks the binding of AFB₁ to the enzyme, thereby reducing the formation of toxic products.(Solomon Abrehame et al., 2025)EGCGDucklingsEGCG (100 mg/kg b.w./d): pretreated for the first 3 d, then given 0.5 h before AFB1 on day 4 for 7 d.Improved growth performance and reduced liver damage.Activates Keap1/Nrf2 and regulates Bax/Bcl-2/Caspase-3.(Wang et al., 2022b)PACsAspergillus flavusPACs (6.25–25 µg/mL),27°C in the dark for 7 d.Inhibits AFB1 synthesis.Reduces oxidative stress within the fungus and blocks toxin synthesis.(Laura et al., 2024)C3GMiceC3G (15, 30, 45 mg/kg b.w./d) was pretreated for 21 d, followed by AFB1 administration for 7 d, with a total period of 28 d.Alleviate splenic immunotoxicity.Regulate the gut-spleen axis and inhibit NLRP3 pyroptosis.(Tang et al., 2026)SILRatsSIL (20 mg/kg b.w./d) in combination with AFB1 for 28 d.Reduces hepatocyte necrosis and liver fibrosis.Antioxidant, anti-inflammatory (downregulates TNF-α) and activates NQO1.(Hassaneen et al., 2023)RatsSIL (20 mg/kg.b.w/d) in combination with AFB1 for 21 d and 28 d.Protect the structure of the reproductive organsAntioxidant and anti-inflammatory; protects against DNA damage and regulates endocrine function.(Hassaneen et al., 2024)BFH12: Bovine Foetal Hepatocyte cell line 12, SBE-HP: Sorghum bicolor sheath hydrophobic extract enriched in apigenin; HLMs: Human liver microsomes, AChE: Acetylcholinesterase, MPO: Myeloperoxidase, AML12: Alpha Mouse Liver 12 cells. Antagonistic effects of flavonoids on AFB1. BFH12: Bovine Foetal Hepatocyte cell line 12, SBE-HP: Sorghum bicolor sheath hydrophobic extract enriched in apigenin; HLMs: Human liver microsomes, AChE: Acetylcholinesterase, MPO: Myeloperoxidase, AML12: Alpha Mouse Liver 12 cells. Flavonoids Certain flavonoids have been shown to possess various pharmacological activities, including the reduction of oxidative stress, inflammation, and lipid accumulation. LUT is a flavonoid with strong antioxidant potential found in various plants (Wang et al., 2020), whereas BAL is extracted from the natural plant Scutellaria baicalensis (Cui et al., 2026). LUT and BAL significantly reduce serum levels of biochemical markers associated with liver damage, reverse AFB1-induced liver injury, and restore liver function. In addition, LUT alleviates AFB1-induced oxidative stress damage by reducing MDA and ROS production while increasing CAT and SOD activity. BAL inhibits the metabolic activation of AFB1, thereby mitigating AFB1 toxicity (Zaki et al., 2023; Lu et al., 2025). API is a naturally occurring flavonoid known as a phytoestrogen, with the highest concentration in celery (Sun et al., 2025). In AFB1-exposed rats, treatment with a hydrophobic extract of high-sorghum bicolor sheath rich in API (SBE-HP) significantly improved redox imbalance and suppressed inflammatory responses (Owumi et al., 2023a). Other flavonoid compounds, such as GNK (Ijaz et al., 2022) and DIOS (Li et al., 2025b), also exhibit similar protective effects against AFB1-induced oxidative stress and inflammation. Flavanols Flavonoids primarily exert their detoxifying effects by mitigating AFB1-induced oxidative damage and inflammatory responses. Among these, the most extensively studied is QUE, which is found in the flowers, leaves, and fruits of many plants, such as onions, apples, daisies, and chamomile (Wang et al., 2020). QUE significantly attenuates AFB1-induced lipid peroxidation and reduces MDA production (Pauletto et al., 2023). In addition, study has shown that QUE also alleviates AFB1-induced inflammatory response (Dai et al., 2024). It is worth noting that QUE can also directly inhibit the biosynthesis of aflatoxins and alleviate AFB1-induced cytotoxicity, hepatotoxicity, and neurotoxicity (Gugliandolo et al., 2020). RUT is found primarily in buckwheat, citrus fruits, and onions (Chunmei and Shuai, 2025). By exerting antioxidant and anti-inflammatory effects, RUT significantly reduced the AFB1-induced increases in IL-6, nitric oxide (NO), and myeloperoxidase (MPO) activity, thereby improving lesions in the rat cerebral cortex and hippocampus (Okoro et al., 2024). FIS, extracted from the lacquer tree (Toxicodendron vernicifluum), significantly reduces the expression of tumor necrosis factor-α (TNF-α) and interleukin-1α (IL-1α) in an AFB1-induced hepatocellular carcinoma model, thereby alleviating the inflammatory response and inhibiting tumor progression (Maurya and Trigun, 2016). Dihydroflavones and dihydroflavonols As subclasses of flavonoids, dihydroflavonoids and dihydroflavonols are also among the effective protective agents against AFB1 poisoning. These two classes of compounds exert a protective effect on the hippocampus and liver exposed to AFB1 toxicity by alleviating oxidative stress, inflammatory responses, and lipid peroxidation, as well as by inhibiting ferroptosis. HES is one of the representative compounds of the dihydroflavonoid class, primarily derived from the young fruits of the genus Citrus in the Rutaceae family (Eberle et al., 2021). It can significantly alleviate AFB1-induced endoplasmic reticulum stress and apoptosis, effectively reversing AFB1-induced cytotoxicity (Song et al., 2023). In addition, Hes can indirectly alleviate AFB1-induced liver damage (Song et al., 2024). DHM, is a flavonoid compound of dihydroflavonol that widely exists in Ampelopsis grossedentata (Wang et al., 2023c). It possesses antioxidant, anti-inflammatory, and anti-apoptotic properties, as well as the ability to modulate the gut microbiota, and helps improve liver and intestinal damage (Zhu et al., 2023, 2025). Flavan-3-ols Flavan-3-ols and their condensates can inhibit AFB1 metabolic activation and oxidative damage in the host, as well as suppress toxin biosynthesis in the fungus. Among these, catechins and EGCG are derived from tea leaves and are the primary active components in tea. Catechins significantly attenuate AFB1-induced cytotoxicity in human intestinal epithelial Caco-2 cells (Caco-2 cells) and human liver HepG2 cells (HepG2 cells) (Solomon Abrehame et al., 2025). EGCG can reduce MDA levels and restore antioxidant markers such as SOD, CAT, GPX, and GSH, thereby alleviating oxidative stress and inhibiting AFB1-induced excessive apoptosis (Wang et al., 2022b), and significantly improving the growth performance and liver damage in ducklings affected by AFB1 exposure. Isoflavones Isoflavonoids such as Tec and IXN can effectively mitigate AFB1-induced toxic damage in both in vitro and in vivo models. Tec found in plants such as Belamcanda chinensis and Pueraria lobata (Ding et al., 2026), which can block the metabolic activation of AFB1, scavenge electrophilic intermediates, and inhibit hepatic lipid peroxidation, thereby alleviating AFB1-induced liver damage. IXN is a natural plant extract derived from hops (Kim et al., 2019). It blocks the metabolic activation of AFB1 and modulates inflammation and tumor progression, thereby mitigating AFB1-induced toxic damage (Anna et al., 2015). Chalcones and anthocyanins Chalcones and anthocyanins can synergistically alleviate AFB1 toxicity by reducing AFBO formation and enhancing Phase II detoxification, while also regulating immune inflammation. PHL is a natural dihydrochalcone found in many fruits and vegetables, especially in apple tree leaves and the Manchurian apricots. Study has shown that Phl exerts a “biphasic” effect on AFB1 at the metabolic level. Specifically, it inhibits AFB1 bioactivation mediated by CYP1A2 and CYP3A4 and induces GST activity, thereby reducing oxidative stress (Gao et al., 2012). C3G belongs to the anthocyanin class, a group of water-soluble natural pigments widely found in plants (Olivas-Aguirre et al., 2016). Anthocyanin treatment has been shown to modulate the gut microbiota, thereby inhibiting pyroptosis and regulating the expression of inflammatory factors via the gut-spleen axis, thus alleviating splenic immunotoxicity (Tang et al., 2026). Other classes Besides the compounds mentioned above, other classes (such as SIL) can also synergistically alleviate AFB1 toxicity. SIL, a plant-derived mixture of polyphenolic flavonoids originating from the fruits and achenes of silybum marianum (Wadhwa et al., 2022), can inhibit the adverse effects of AFB1 on AST, ALT activity, serum albumin (ALB), ferritin (FER), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), and the expression of related genes, and significantly improves AFB1-induced liver damage (Hassaneen et al., 2023). It also exerts a significant mitigating effect on AFB1-induced male reproductive toxicity, helping to maintain testicular structure and protect reproductive organ function (Hassaneen et al., 2024). To conclude, flavonoids (such as flavones, flavanols, isoflavones, and anthocyanins) show detoxification effects against AFB1 in vitro and in vivo. Some also inhibit aflatoxin biosynthesis. However, most studies focus on in vitro mechanisms, with insufficient attention to bioavailability, metabolism, or gut microbiota interactions. Future research should conduct in vivo pharmacokinetic studies and large-scale animal trials to support applications in food safety and feed development. Protective mechanisms of flavonoids against AFB1-induced toxicity Flavonoids play a key role in preventing and alleviating AFB1-induced toxicity. Table 2 summarizes the mechanisms by which representative flavonoid compounds exert protective effects against AFB1-induced damage, primarily including the reduction of oxidative stress, the attenuation of inflammatory responses, the inhibition of apoptosis and ferroptosis, and the inhibition of enzyme metabolism. Oxidative stress Oxidative stress refers to a harmful state in which the rate of free radical production (primarily ROS) exceeds the antioxidant clearance capacity, leading to an imbalance between oxidation and antioxidation (Herbetko et al., 2026). This condition often results in lipid peroxidation, mitochondrial dysfunction, DNA damage, and protein damage. As shown in Fig. 2, flavonoids mitigate AFB1-induced oxidative damage by activating the Nrf2 signaling pathway, scavenging free radicals, and inhibiting enzyme activity. LUT, EGCG, and DHM alleviate oxidative stress by reducing MDA and ROS levels and upregulating antioxidant enzymes (SOD, CAT, GPx, and GSH), thereby reversing liver damage (Wang et al., 2022b; Zaki et al., 2023; Zhu et al., 2023). Phl exerts anti-AFB1 carcinogenic effects by activating the Nrf2/ARE pathway, increasing GST activity, and inhibiting AFB1 production (Gao et al., 2012). Naringenin scavenges free radicals via metal ion chelation and hydrogen donation; in mouse models, it enhances antioxidant capacity through the PPARγ/Nrf2 pathway (Chen et al., 2026). SIL activates the antioxidant gene NQO1 to exert its protective effects (Hassaneen et al., 2024). Collectively, these findings indicate that flavonoids play a key role in alleviating AFB1-induced oxidative damage via a multi-target antioxidant mechanism. Molecular mechanism of flavonoids in alleviating AFB1-induced oxidative stress damage. Flavonoids alleviate oxidative stress and AFB1-induced cytotoxicity by activating the Keap1-Nrf2-ARE antioxidant pathway (upregulating HO-1, CAT, etc.) and inhibiting AFB1 activation mediated by CYP1A2/3A4. Apoptosis/pyroptosis Apoptosis is a form of autonomous, orderly cell death that maintains internal homeostasis and is essential for normal physiological function (Chai et al., 2025). Pyroptosis, a type of programmed cell death mediated by gasdermin proteins, triggers a robust inflammatory response upon activation and thus plays a crucial role in host defense against pathogen infections (Eldakhakhny et al., 2025). As shown in Fig. 3, flavonoids significantly attenuate AFB1-induced programmed cell death by regulating the expression of apoptosis-related proteins and inhibiting the pyroptosis pathway. SBE-HP, which is rich in API, prevents apoptosis in liver and kidney cells by reducing the activity of caspase-9 and caspase-3 (Owumi et al., 2023a) . EGCG inhibits excessive apoptosis in hepatocytes by regulating the expression of Bax, Bcl-2, and caspase-3 (Wang et al., 2022b). Hes reduces AFB1 activation of the aryl hydrocarbon receptor and attenuates endoplasmic reticulum stress-induced apoptosis (Song et al., 2023). With regard to pyroptosis, C3G inhibits NLRP3/caspase-1/GSDMD-mediated pyroptosis and the release of IL‑1β/IL-18 in the spleen by regulating the gut-spleen axis (Tang et al., 2026). IXN, on the other hand, exerts its antitumor effects by inducing autophagy or oxidative stress-dependent apoptosis in tumor cells (Anna et al., 2015). Molecular mechanisms by which flavonoids alleviate AFB1-induced inflammation, apoptosis, and pyroptosis. Flavonoids reduce cellular damage by inhibiting inflammation-related signaling pathways (TLR4, NF-κB, MAPK, STAT3), thereby decreasing the production of downstream pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and Caspase-1/9-mediated apoptosis and pyroptosis. In summary, flavonoids regulate cell death through multiple pathways, offering an important therapeutic strategy against AFB1 intoxication. Inflammation Inflammation is a complex biological response to harmful stimuli, involving immune cell activation and cytokine release (Matsuda et al., 2018). While critical for host defense, dysregulated inflammation can lead to tissue injury and disease progression. Flavonoids effectively attenuate AFB1-induced inflammatory responses by inhibiting the TLR4/MAPK/NF-κB/NLRP3 signaling pathway, as shown in Fig. 4. The API-rich extract reduces inflammation by lowering IL-1β levels and increasing IL-10 levels (Owumi et al., 2023a). Que inhibits the IL-6/STAT3 signaling pathway through specific binding to IL-6 and STAT3, thereby reducing the inflammatory response (Dai et al., 2024). DIOS alleviates oxidative stress and inflammation by inhibiting the NF-κB pathway and activating the PI3K/AKT pathway (Li et al., 2025b). Rut significantly reduces IL-6 and nitric oxide levels as well as myeloperoxidase activity, thereby alleviating AFB1-induced neurotoxicity (Okoro et al., 2024). SIL exerts anti-inflammatory effects by downregulating TNF-α expression, thereby reducing hepatocyte necrosis and liver fibrosis (Hassaneen et al., 2024). Naringin reduces the production of TNF-α, IL-6, and IL-8, thereby promoting hepatic self-repair (Wang et al., 2021). These findings confirm that flavonoids are effective natural agents for counteracting AFB1-induced inflammatory damage. Molecular mechanism by which flavonoids reduce ferroptosis. Flavonoids synergistically inhibit ferroptosis by activating the Xc-GSH-GPX4 axis and the Nrf2-ARE/HO-1 antioxidant system, modulating the PI3K/AKT/mTOR pathway, and suppressing inflammatory factors. Ferroptosis Ferroptosis is an iron-dependent regulated cell death driven by lipid peroxide accumulation and primarily governed by the GPX4 and SLC7A11 systems (Jin et al., 2026). Flavonoids antagonize AFB1-induced ferroptosis by regulating iron metabolism and inhibiting lipid peroxidation (Fig. 4). Hes inhibits ferroptosis via the PI3K/AKT/mTOR/ULK1 pathway, reducing lipid peroxidation and liver fibrosis, and also alleviates liver damage by regulating iron metabolism and suppressing inflammation, similar to phenolic compounds that counteract fumonisin toxicity by activating the SLC7A11-GSH-GPX4 axis or inhibiting ferritinophagy (Song et al., 2024). Lico A (a chalcone from licorice) reduces the pro-ferroptotic protein ACSL4 and MDA levels while increasing anti-ferroptotic proteins (GPX4, SLC7A11, FSP1) and GSH, thereby inhibiting ferroptosis, and it also downregulates AFB1-induced apoptosis-related proteins (caspase-3, Bax, and Bcl-2) and upregulates antioxidant proteins (Nrf2, GCLM, and HO-1) (Xia et al., 2024). Total flavonoids from Dipsacus asper (TFRD) promote bone repair and possess anti-inflammatory and antioxidant properties. Study has shown that ferroptosis may cause AFB1-induced hepatotoxicity in chickens via the microbiota-gut-liver axis, and TFRD may mitigate liver damage by suppressing oxidative stress, hepatic lipid accumulation, increasing GSH, and reversing ferroptosis-related gene expression (Huang et al., 2023). Gut microbiome The gut microbiota is a complex microbial community that regulates host metabolism, immunity, and intestinal barrier integrity (Fehily et al., 2021), and its dysbiosis contributes to AFB1-induced toxicity. Flavonoids exert protective effects against AFB1 toxicity by reshaping the gut microbiota and restoring metabolic homeostasis (Fig. 5). In mice exposed to AFB1, C3G significantly attenuates AFB1-induced splenic immunotoxicity. This protective mechanism is associated with restoration of gut microbiota and metabolic homeostasis, as well as inhibition of NLRP3/caspase‑1/GSDMD‑mediated pyroptosis and IL‑1β/IL-18 release via the gut-spleen axis (Tang et al., 2026). DHM reverses AFB1-induced downregulation of tight junction proteins, activates the Nrf2/HO-1 signaling pathway, reduces caspase-3 and Bax expression, and increases Bcl-2 expression (Zhu et al., 2023). Additionally, DHM improves microbial diversity, thereby mitigating AFB1-induced intestinal damage (Huang et al., 2023). Future research should further investigate the bidirectional interactions between flavonoids and the gut microbiota to optimize strategies for AFB1 detoxification. Molecular mechanisms by which flavonoids improve intestinal barrier function under AFB1 exposure via the “gut-liver axis.” Flavonoids alleviate liver and spleen damage by upregulating intestinal tight junction proteins, activating the Nrf2 antioxidant pathway, and inhibiting pyroptosis and apoptosis mediated by the NLRP3 inflammasome. Discussion Summary of key findings Stepping back, what the evidence actually shows is that flavonoids fight AFB1 toxicity through a set of overlapping defences, not a single pathway. At the most direct level, they activate Keap1-Nrf2/ARE, driving up SOD, CAT, GSH, and HO-1 while scavenging ROS. Further downstream, NF-κB, JAK/STAT, and PI3K/AKT are dialled back, which dampens inflammation and restores some balance between pro- and anti-apoptotic signals. A few flavonoids, Que, Cat, and Phl stand out, go further still, directly interfering with AFB1 metabolism by suppressing CYP450-mediated epoxidation and inducing phase II enzymes like GST, cutting the pool of genotoxic aflatoxin-8,9-epoxide before it can do damage. And then there is what happens in the gut. A portion of ingested flavonoids never gets absorbed and instead reaches the colon, where it reshapes the microbial community and, through the gut–liver and gut–spleen axes, ends up protecting organs it never directly touched. Clinical translation and challenges Flavonoids generally suffer from low oral bioavailability and unstable metabolism in the body, which limits their clinical translation. Overcoming this bottleneck may require the development of pharmaceutical strategies such as nanoencapsulation and phospholipid complexes (Zhu et al., 2023a) . AFB1 primarily targets the liver to exert its toxic effects. Most studies have focused on animal models, where it has been demonstrated that flavonoids can alleviate AFB1-induced liver damage through antioxidant effects, repair of the intestinal barrier, and remodeling of the gut microbiota; however, the extrapolation of these findings from poultry to mammals and humans requires systematic validation (Tao et al., 2023). Research has shown that certain flavonoids, such as proanthocyanidins, can selectively inhibit AFB1 synthesis at concentrations that do not affect fungal growth, representing an environmentally friendly strategy for mycotoxin control. However, the development of a homogeneous formulation of these active ingredients in grains and the verification of its reproducibility across strains remain key issues that must be resolved prior to industrialization (Cadenillas et al., 2024). In summary, we propose four approaches: (1) conduct cross-species validation and coordinated preclinical studies, and carry out human pharmacokinetic and dietary intervention studies in regions with high prevalence of AFB1; (2) develop formulations that enhance bioavailability, such as phospholipid complexes and nano-encapsulation; (3) incorporate gut microbiota analysis into the design of preclinical and clinical studies; and (4) standardize the quality of extracts. Conclusion and future perspectives Research indicates that flavonoids hold significant potential for mitigating AFB1 toxicity through multi-target and multi-pathway mechanisms rather than a single mode of action. Specifically, flavonoids alleviate oxidative stress by scavenging ROS and enhancing antioxidant systems (e.g., SOD, CAT, and GSH). They also regulate key signaling pathways such as NF‑κB, JAK/STAT, and PI3K/AKT, thereby reducing inflammation and inhibiting apoptosis. Moreover, certain representative compounds (e.g., Que, Cat, and Phl) influence AFB1 metabolism by inhibiting CYP450-mediated AFBO formation or promoting phase II detoxifying enzyme activity (e.g., GST), thus accelerating toxin clearance. Additionally, flavonoids may indirectly attenuate systemic toxicity by modulating the gut microbiota and acting through the gut-liver and gut-spleen axes. Different flavonoids exhibit distinct antioxidant, anti-inflammatory, and metabolic regulatory profiles, suggesting potential complementary benefits in combination. Nevertheless, current research has several limitations. First, most studies focus on single compounds or single targets, lacking a systematic understanding of synergistic effects among multiple components. Second, existing evidence is primarily derived from cellular and animal studies, with limited clinical validation. Thus, safety, effective dosages, and long-term risks require further evaluation. Third, flavonoids generally suffer from low bioavailability and complex in vivo metabolism, which restricts their efficacy. Fourth, although AFB1 toxicity involves multi-organ and multi-level regulation, most related studies are isolated and lack comprehensive integration. Future research should address these gaps through the following approaches: (1) systematically elucidating action mechanisms by integrating multi-omics technologies (transcriptomics, metabolomics, proteomics) with network toxicology; (2) strengthening investigations of multi-component or compound formulations to explore synergistic effects; (3) improving bioavailability and targeting via structural modification or nanodelivery; (4) conducting standardized animal experiments and preclinical/clinical studies to enhance translational potential; and (5) further exploring the role of gut-host interactions in detoxification processes. In conclusion, flavonoids, as widely available and relatively safe natural bioactive compounds, show great promise for counteracting AFB1 toxicity. However, transitioning from basic research to practical application will require more systematic and in-depth investigations. CRediT authorship contribution statement Huanhuan Shi: Conceived and designed the study, drafted the original manuscript, and contributed to the critical review and editing of the manuscript. Jie Mu: Conceived and designed the review, conducted the literature search and screening, and drafted the original manuscript. Rong Li: Contributed to the visualization and preparation of figures, and critically reviewed and edited the manuscript. Kesong Zhu: Conducted the literature search and drafted the original manuscript. Yiming Long: Conducted the literature search and screening, and drafted the original manuscript. Yalin Lin: Contributed to the analysis and interpretation of the literature, and critically reviewed and edited the manuscript. Danchen Zhao: Contributed to the visualization of the conceptual framework, and critically reviewed and edited the manuscript. Mengnan Qu: Supervised the project, acquired funding, and critically reviewed and edited the manuscript. All authors have reviewed and given their explicit approval to the final manuscript. They accept full responsibility for all aspects of the work and affirm that any questions regarding the accuracy or integrity of any part will be properly investigated and resolved. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgements This work was supported by grants from the Hubei University of Science and Technology Program (No. BK202505). Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.psj.2026.107774. Supplementary materials References Associated Data Supplementary Materials